Commentary on the national kidney foundation position paper on analgesics and the kidney

American Journal of Kidney Diseases

Volumn 28, Issue 5, 1996, Pages 783-785

  Delzell, E ^a   Shapiro, S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; BARBITURIC ACID DERIVATIVE; CAFFEINE; CODEINE; PARACETAMOL; PHENACETIN; PYRAZOLONE DERIVATIVE;

DRUG ABUSE; DRUG MIXTURE; EPIDEMIOLOGICAL DATA; HUMAN; METHODOLOGY; NEPHROTOXICITY; NOTE;

EID: 0029855634     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(96)90266-8     Document Type: Note

References (16)

1. WL Henrich LE Agodoa B Barrett WM Bennett RC Blantz VM Buckalew VD D'Agati ME Debroe GG Duggin G Eknoyan MM Elseviers RA Gomez GR Matzke GA Porter S Sabatini JS Stoff GE Striker JF Winchester Analgesics and the kidney: Summary and recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the National Kidney Foundation Am J Kidney Dis 27 1996 162 165
2. UC Dubach B Rosner E Pfister Epidemiologic study of abuse of analgesics containing phenacetin Renal morbidity and mortality N Engl J Med 308 1983 357 362
3. UC Dubach B Rosner T Sturmer An epidemiologic study of abuse of analgesic drugs Effects of phenacetin and salicylate on mortality and cardiovascular morbidity (1968 to 1987) N Engl J Med 324 1991 155 160
4. MM Elseviers ME De Broe A long-term prospective controlled study of analgesic abuse in Belgium Kidney Int 48 1995 1912 1919
5. M McCredie JH Stewart JF Mahoney Is phenacetin responsible for analgesic nephropathy in New South Wales? Clin Nephrol 17 1982 134 140
6. TG Murray PD Stolley JC Anthony R Schinnar E Hepler-Smith JL Jeffreys Epidemiologic study of regular analgesic use and end-stage renal disease Arch Intern Med 143 1983 1687 1693
7. TV Perneger PK Whelton MJ Klag Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs N Engl J Med 331 1994 1675 1679
8. DP Sandler JC Smith CR Weinberg VM Buckalew VW Dennis WB Blythe WP Burgess Analgesic use and chronic renal disease N Engl J Med 320 1989 1238 1243
9. DP Sandler CR Weinberg Analgesic use and chronic renal disease N Engl J Med 321 1989 1126 1127 (letter)
10. M Morlans J Laporte X Vidal D Cabeza PD Stolley End-stage renal disease and non-narcotic analgesics: A case-control study Br J Clin Pharmacol 30 1990 717 723
11. W Pommer E Bronder E Greiser U Helmert HJ Jesdinsky A Klimpel K Borner M Molzahn Regular analgesic intake and the risk of end-stage renal failure Am J Nephrol 9 1989 403 412
12. M McCredie MS Coates JM Ford APS Disney JJ Auld JH Stewart Geographical distribution of cancers of the kidney and urinary tract and analgesic nephropathy in Australia and New Zealand Aust N Z J Med 20 1990 684 694
13. JL Vanherweghem D Even-Adin Epidemiology of analgesic nephropathy in Belgium Clin Nephrol 17 1982 129 133
14. MM Elseviers ME De Broe Analgesic nephropathy in Belgium is related to the sales of particular analgesic mixtures Nephrol Dial Transplant 9 1994 41 46
15. VW Buckalew HM Schey Renal disease from habitual antipyretic analgesic consumption: An assessment of the epidemiologic evidence Medicine 11 1986 291 303
16. M McCredie JH Stewart TH Matthew APS Disney JM Ford The effect of withdrawal of phenacetin-containing analgesics on the incidence of kidney and urothelial cancer and renal failure Clin Nephrol 31 1989 35 39